More on EVMN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.3 Score)

Upcoming Events

- Earnings (11/9/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Evommune (NY:EVMN)
Delayed: 13.08 --0 (-0%)
Prev. Close $13.08  
Open$13.08 
52 Wk High$ 
52 Wk Low$ 
Day High$13.08 
Day Low$13.08 
P/E N/A  
EPS$ 
Volume22,271 


Sep 9, 2026 07:23 AM Evommune Inc (EVMN) PT Lowered to $21 at RBC Capital
Sep 9, 2026 06:58 AM Clear Street Reiterates Buy Rating on Evommune Inc (EVMN) Amid 15% Drop
Sep 9, 2026 06:02 AM Form 424B3 Evommune, Inc.
Sep 9, 2026 06:01 AM Form 8-K Evommune, Inc. For: Sep 08
Sep 8, 2026 05:43 PM Evommune's EVO756 fails atopic dermatitis trial endpoints
Sep 8, 2026 05:43 PM Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Atopic Dermatitis
Aug 26, 2026 06:20 AM Needham Starts Evommune Inc (EVMN) at Buy
Aug 14, 2026 04:27 PM Form SCHEDULE 13G/A Evommune, Inc. Filed by: Andera Partners
Aug 14, 2026 10:39 AM Form SCHEDULE 13G Evommune, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Aug 7, 2026 04:20 PM Evommune, Inc. (EVMN) Misses Q2 EPS by 20c
View All Articles

Entities mentioned with EVMN

View All Entities